Streptococcus suis serotype 2 enolase interaction with host brain microvascular endothelial cells and RPSA-induced

Hongtao Liu1, Siyu Lei2, Li Jia1

  • 1Key Laboratory of Zoonosis, Ministry of Education, Institute of Zoonosis/College of Veterinary Medicine, Jilin University, Changchun, Jilin, 130062, People's Republic of China.

Veterinary Research
|February 23, 2021
PubMed

Insights

Streptococcus suis serotype 2 enolase binds to host protein RPSA, triggering a signaling cascade that increases blood-brain barrier permeability and promotes meningitis. This discovery offers new therapeutic targets for bacterial meningitis.

Area of Science:

  • Molecular Medicine
  • Microbiology
  • Neuroscience

Background:

  • Host-pathogen interactions are key therapeutic targets.
  • Streptococcus suis serotype 2 (SS2) causes meningitis in humans and pigs.
  • The SS2 enolase (Eno) virulence factor's host receptor and mechanism for altering blood-brain barrier (BBB) integrity are unknown.

Purpose of the Study:

  • To identify the host cell membrane receptor for SS2 Eno.
  • To elucidate the molecular mechanisms by which SS2 Eno disrupts BBB integrity.
  • To explore potential therapeutic strategies for SS2 meningitis.

Main Methods:

  • Binding assays to identify SS2 Eno receptor on porcine brain microvascular endothelial cells.
  • Western blotting and kinase assays to analyze intracellular signaling pathways (p38/ERK-eIF4E).
  • Assessment of heat-shock protein family D member 1 (HSPD1) expression and host-cell apoptosis.
  • Evaluation of BBB permeability.

Main Results:

  • SS2 Eno binds to 40S ribosomal protein SA (RPSA) on the surface of porcine brain microvascular endothelial cells.
  • This interaction activates intracellular p38/ERK-eIF4E signaling.
  • Activation promotes HSPD1 expression, initiates host-cell apoptosis, and increases BBB permeability, facilitating bacterial invasion.
  • Novel roles for RPSA and HSPD1 in BBB integrity were revealed.

Conclusions:

  • SS2 enolase utilizes RPSA as a receptor to disrupt BBB integrity via p38/ERK-eIF4E-HSPD1 signaling.
  • This mechanism contributes to Streptococcus suis serotype 2 meningitis pathogenesis.
  • RPSA and HSPD1 are identified as novel targets for therapeutic intervention in meningitis.